Down 9.0% in 4 Weeks, Here's Why Abbott (ABT) Looks Ripe for a TurnaroundZacks Investment Research • 07/18/25
Abbott Laboratories CEO calls post-earnings stock decline 'a little bit of an overreaction'CNBC • 07/17/25
Abbott Stock Falls in Pre-Market Despite Q2 Earnings and Sales BeatZacks Investment Research • 07/17/25
Abbott Laboratories shares slide as cautious guidance overshadows Q2 revenue beatProactive Investors • 07/17/25
Abbott Laboratories Issues Weak Earnings Forecast, Joins MP Materials And Other Big Stocks Moving Lower In Thursday's Pre-Market SessionBenzinga • 07/17/25
Dow Jones down and Nasdaq flat as Abbott outlook disappoints, Pepsi impressesProactive Investors • 07/17/25
Abbott Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings CallBenzinga • 07/16/25